Enhancer Detail

Comprehensive information about experimentally validated enhancers

About Enhancer
Enhancer ID: E_00312
Species: Homo sapiens
Position : chr8:41184163-41184463
Year: 2023
Title: SOX17 enhancer variants disrupt transcription factor binding and enhancer inactivity drives pulmonary hypertension
Genome Build: hg19
Enhancer Type: Enhancer
Condition: Disease
Disease Name: pancreatic ductal adenocarcinoma
PMID:  37066790
MONDO: MONDO:0005147
Tissue: Pancreas
Tissue Ontology ID: UBERON:0001264
Cell Source: PacR
CVCL ID:
Cell Type: pancreatic ductal adenocarcinoma cell
Cell Ontology ID: CL:0000066
Experiment Type: Enhancer activity assay, Functional perturbation assay
High Throughput Method: ChIP-seq, RNA-seq
Low Throughput Method: Luciferase Reporter Assay, CRISPRi, CRISPR Knockout, EMSA, ChIP-RT-qPCR
About Target Gene
Target gene : SOX17
About TF
TF name : HOXA5
About Regulatory State
Regulatory State : Active
Upstream Pathway Annotation of TF
GeneName Pathway Name Source Gene Number
Enhancer Associated Network
Overlapping Enhancers (hg19)
No overlapping enhancers found in hg19 at this locus.
Expression of Target Genes for the Enhancer